Sharon Jackson
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 15
- Chronic Lymphocytic Leukemia Research 9
- Hemoglobinopathies and Related Disorders 3
-
- Lymphoma Diagnosis and Treatment 10
- Co-authors
- Jim A. Julian (2 shared papers)Susan Solymoss (2 shared papers)Jack Hirsh (2 shared papers)Michael Gent (2 shared papers)Jeffrey S. Ginsberg (1 shared paper)Paul Ockelford (2 shared papers)Betsy MacKinnon (2 shared papers)James D. Douketis (2 shared papers)
- Journals
- Blood (10 papers)Journal of Clinical Oncology (5 papers)British Journal of Haematology (2 papers)Clinical Cancer Research (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)
- Partner nations
- New ZealandUnited KingdomUnited States
In The Last Decade
Sharon Jackson
28 papers receiving 848 citations
Sharon Jackson's Hit Papers
Peers
Comparison fields: 5 of 68
- Internal Medicine 151
- Genetics 217
- Pathology and Forensic Medicine 338
- Hematology 145
- Dermatology 73
Countries citing papers authored by Sharon Jackson
This map shows the geographic impact of Sharon Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Jackson more than expected).
Fields of papers citing papers by Sharon Jackson
This network shows the impact of papers produced by Sharon Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Jackson. The network helps show where Sharon Jackson may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharon Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 225 | |
| 2 | 2006 | 176 | |
| 3 | Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort Hit paper breakdown → | 2022 | 140 |
| 4 | 1988 | 65 | |
| 5 | 2013 | 61 | |
| 6 | 2017 | 40 | |
| 7 | 2020 | 32 | |
| 8 | 2005 | 21 | |
| 9 | 2021 | 16 | |
| 10 | 1998 | 16 | |
| 11 | 2018 | 15 | |
| 12 | 2019 | 14 | |
| 13 | 1991 | 10 | |
| 14 | 2015 | 9 | |
| 15 | 2005 | 7 | |
| 16 | 2016 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2023 | 3 | |
| 20 | 2022 | 3 |
About Sharon Jackson
Sharon Jackson is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Molecular Biology, having authored 31 papers that have together received 884 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Protein Degradation and Inhibitors (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Internal Medicine (151 citations), Genetics (217 citations), Pathology and Forensic Medicine (338 citations), Hematology (145 citations) and Dermatology (73 citations). Sharon Jackson has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include Jim A. Julian, Susan Solymoss, Jack Hirsh, Michael Gent, Jeffrey S. Ginsberg, Paul Ockelford, Betsy MacKinnon, James D. Douketis, Alexander G.G. Turpie and Clive Kearon. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Clinical Cancer Research and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.